Barclays
KYTH

Barclays’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Barclays’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-251,154
Closed -$18.6M – 7237
2015
Q3 		$18.6M Sell
251,154
-13,909
-5% -$1.04M 0.02% 637
2015
Q2 		$19.9M Buy
265,063
+256,342
+2,939% +$13.7M 0.02% 654
2015
Q1 		$437K Buy
8,721
+2,442
+39% +$102K ﹤0.01% 3724
2014
Q4 		$213K Buy
6,279
+1,127
+22% +$39.3K ﹤0.01% 4580
2014
Q3 		$165K Buy
5,152
+248
+5% +$8.73K ﹤0.01% 4921
2014
Q2 		$186K Buy
4,904
+1,874
+62% +$65.4K ﹤0.01% 4886
2014
Q1 		$118K Buy
3,030
+1,090
+56% +$48.8K ﹤0.01% 5298
2013
Q4 		$71K Buy
1,940
+1,556
+405% +$64.5K ﹤0.01% 5941
2013
Q3 		$17K Sell
384
-147
-28% -$4.4K ﹤0.01% 6606
2013
Q2 		$14K Buy
+531
New +$12.2K ﹤0.01% 7007

Barclays's KYTH Position: Q4 2015 in Review

Barclays sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 251,154 shares — an estimated $18.6M sold.

Barclays first reported a position in KYTH in Q2 2013 and held it in 10 quarters. The position peaked at $19.9M in Q2 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • Barclays reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • Barclays sold 251,154 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $18.6M.
  • Barclays first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 10 quarters.
  • Barclays's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $19.9M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Barclays's 13F filing for Q4 2015, filed 12 Feb 2016.